Topic: Sustainability

As demand for siRNA therapeutics continues to grow, manufacturers face increasing pressure to deliver larger quantities of drug…

As the leading peptide manufacturer, Bachem is at the forefront of innovative synthesis methods. One cutting-edge approach is…

    The rising demands for therapeutic oligonucleotides requires scalable, efficient, and more sustainable manufacturing solutions. Stirred bed…

As the demand for peptide-based therapeutics continues to grow, the need for innovative, cost-efficient, and environmentally friendly manufacturing…

  Linear synthesis by continuous-flow SPOS is the current state-of-the-art technology to manufacture oligonucleotide APIs. A very promising alternative,…

Oligonucleotide-based therapeutics are transforming modern medicine, offering targeted solutions for genetic disorders, cancer, cardiovascular disease, and CNS conditions.…

Amino acid derivatives (AADs) are essential starting materials for solid-phase peptide synthesis, crucial for the development of peptide-based therapeutics…

  Linear synthesis by continuous-flow SPOS is the current state-of-the-art technology to manufacture oligonucleotide APIs. A very promising…